Sanara Medtech Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.4% | -99.1% | +305.6% | +148.4% | -10.1% | +232.3% | -54.0% | -0.7% | +216.1% | +142.7% | -46.9% | +47.1% | +52.5% | +28.1% | +63.3% | +14.5% | -7.4% | +101.6% | +32.5% | +54.9% | +89.9% | +41.8% | +33.4% | +19.0% | |
| – | +6.4% | -98.7% | +298.8% | +241.1% | -28.9% | +15.6% | +86.9% | +165.0% | -51.3% | +48.6% | -0.1% | -0.7% | +1.4% | +11.0% | +5.8% | -14.6% | -37.0% | +138.3% | +33.7% | +43.0% | +175.2% | +23.5% | +3.7% | +25.1% | |
| – | -4.4% | -99.9% | +440.7% | -1,201.8% | – | – | -131.2% | – | – | +278.9% | -73.4% | +149.0% | +95.9% | +35.6% | +84.0% | +20.5% | -3.1% | +98.1% | +32.3% | +56.3% | +80.8% | +44.7% | +37.4% | +18.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,290.2% | +502.7% | +22.7% | +38.0% | -11.1% | |
| – | – | – | – | – | – | – | – | – | +225.8% | -6.4% | +19.8% | +15.9% | +0.6% | -11.7% | +40.8% | +10.7% | +8.7% | +127.8% | +42.9% | +50.2% | +63.9% | +19.1% | +39.8% | +2.8% | |
| – | +8.4% | -19.8% | +323.3% | -86.9% | -39.5% | +67.8% | +100.7% | -37.2% | +235.9% | -6.6% | +79.3% | -33.0% | +0.8% | -11.5% | +40.4% | +10.7% | +8.7% | +128.5% | +42.9% | +53.7% | +78.0% | +18.0% | +38.9% | -1.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -516.7% | – | – | – | – | – | – | – | |
| – | -80.7% | +148.7% | -97.6% | +557.9% | +165.6% | +1.0% | -89.5% | +3,175.7% | +69.4% | -67.3% | +364.0% | +46.8% | -83.6% | -39.8% | -1.4% | -27.3% | -31.7% | +22.3% | -89.1% | -93.8% | +39,948.7% | +67.1% | +557.5% | +116.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -324.8% | – | – | – | – | -281.3% | – | – | – | – | – | – | – | |
| – | – | -203.5% | – | -103.1% | – | +1.0% | -89.5% | +3,087.0% | +217.0% | +650.2% | -66.3% | -113.7% | – | – | -115.5% | – | – | +651.9% | -166.0% | – | – | – | – | – | |
| – | -330.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -281.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -177.6% | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.